In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 7, Pages 1992
Publisher
MDPI AG
Online
2018-07-09
DOI
10.3390/ijms19071992
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of Nrf2 signaling in counteracting neurodegenerative diseases
- (2018) Albena T. Dinkova-Kostova et al. FEBS Journal
- Role of mitochondrial ROS in the brain: from physiology to neurodegeneration
- (2018) Plamena R. Angelova et al. FEBS LETTERS
- The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets
- (2018) Santa Mammana et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson’s disease: possible involvement of different binding sites at the PPARγ receptor
- (2018) Concepción García et al. Journal of Neuroinflammation
- Eruca sativa seed extract: A novel natural product able to counteract neuroinflammation
- (2018) Agnese Gugliandolo et al. Molecular Medicine Reports
- 13 reasons why the brain is susceptible to oxidative stress
- (2018) James Nathan Cobley et al. Redox Biology
- Cannabinoid CB2 receptors are involved in the protection of RAW264.7 macrophages against the oxidative stress: an in vitro study
- (2017) Sabrina Giacoppo et al. EUROPEAN JOURNAL OF HISTOCHEMISTRY
- Protective effect of naringin against the LPS-induced apoptosis of PC12 cells: Implications for the treatment of neurodegenerative disorders
- (2017) Hui Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- CNS inflammation and neurodegeneration
- (2017) Tanuja Chitnis et al. JOURNAL OF CLINICAL INVESTIGATION
- Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications
- (2017) Zewen Liu et al. Oxidative Medicine and Cellular Longevity
- Cannabidiol: State of the art and new challenges for therapeutic applications
- (2017) Simona Pisanti et al. PHARMACOLOGY & THERAPEUTICS
- KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington's disease patients
- (2017) Luisa Quinti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An update on PPAR activation by cannabinoids
- (2016) Saoirse Elizabeth O'Sullivan BRITISH JOURNAL OF PHARMACOLOGY
- Inflammatory Mechanisms and Oxidative Stress as Key Factors Responsible for Progression of Neurodegeneration: Role of Brain Innate Immune System
- (2016) Jerzy Leszek et al. CNS & Neurological Disorders-Drug Targets
- Conditioned medium of periodontal ligament mesenchymal stem cells exert anti-inflammatory effects in lipopolysaccharide-activated mouse motoneurons
- (2016) Thangavelu Soundara Rajan et al. EXPERIMENTAL CELL RESEARCH
- Role of neuroinflammation in neurodegenerative diseases (Review)
- (2016) WEI-WEI CHEN et al. Molecular Medicine Reports
- Does the Interdependence between Oxidative Stress and Inflammation Explain the Antioxidant Paradox?
- (2016) Subrata Kumar Biswas Oxidative Medicine and Cellular Longevity
- Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
- (2016) Eri H. Kobayashi et al. Nature Communications
- VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease
- (2016) Javier Díaz-Alonso et al. Scientific Reports
- Cannabidiol (CBD) and its analogs: a review of their effects on inflammation
- (2015) Sumner Burstein BIOORGANIC & MEDICINAL CHEMISTRY
- Nrf2—a therapeutic target for the treatment of neurodegenerative diseases
- (2015) Delinda A. Johnson et al. FREE RADICAL BIOLOGY AND MEDICINE
- Role of the Keap1/Nrf2 pathway in neurodegenerative diseases
- (2015) Hiromi Yamazaki et al. PATHOLOGY INTERNATIONAL
- Neuroprotective Properties of Cannabigerol in Huntington’s Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice
- (2014) Sara Valdeolivas et al. Neurotherapeutics
- A Cannabigerol Derivative Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis
- (2014) Francisco J. Carrillo-Salinas et al. PLoS One
- The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
- (2014) John D. Hayes et al. TRENDS IN BIOCHEMICAL SCIENCES
- Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease
- (2013) Francesca Borrelli et al. BIOCHEMICAL PHARMACOLOGY
- A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis
- (2012) Aitor G. Granja et al. Journal of Neuroimmune Pharmacology
- Nitric oxide synthases: regulation and function
- (2011) U. Forstermann et al. EUROPEAN HEART JOURNAL
- The Multiplicity of Action of Cannabinoids: Implications for Treating Neurodegeneration
- (2010) Aoife Gowran et al. CNS Neuroscience & Therapeutics
- Up-regulated expression of peroxisome proliferator-activated receptor γ in the hypothalamic–pituitary–adrenal axis of weaned pigs after Escherichia coli lipopolysaccharide challenge
- (2009) Yu Lan Liu et al. VETERINARY JOURNAL
- Increased expression of the peroxisome proliferator-activated receptor γ in the immune system of weaned pigs after Escherichia coli lipopolysaccharide injection
- (2008) Yulan Liu et al. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
- Cannabinoids as Therapeutic Agents for Ablating Neuroinflammatory Disease
- (2008) G. Cabral et al. Endocrine Metabolic & Immune Disorders-Drug Targets
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started